← All trials
NCT04933916
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 10, 2021
- Primary completion
- Feb 28, 2022
- Completion date
- Aug 31, 2022
- First posted
- Jun 22, 2021
- Last posted
- Jun 22, 2021
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Embera NeuroTherapeutics, Inc.Lead sponsor
- Embera NeuroTherapeutics, Inc.Study chair
- Rose Research Center, LLCCollaborator
- Foundation for a Smoke-Free WorldCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.